A Study of Seltorexant in Participants With Probable Alzheimer's Disease

Summary

The purpose of this study is to investigate the effect of seltorexant versus placebo on the sum of Agitation and Aggression domain scores (A plus A) of the Neuropsychiatric Inventory-Clinician rating (NPI-C) in participants with probable Alzheimer's Disease (AD) with clinically significant agitation/aggression.

Timeline

Start

2022-05-19

Primary completion

2023-11-10

Completion

2023-11-10

Drugs

Indications